Overview
LumiMeds is a telehealth weight-care platform selling compounded semaglutide and compounded tirzepatide directly to consumers, with pricing that sits at the very bottom of the market. The company advertises compounded semaglutide plans from $89 per month and compounded tirzepatide from $125 per month, and states plainly on its site that no membership is required.
The pricing architecture is unusually clear for this segment. LumiMeds publishes tiered plan lengths rather than dose-tiered prices: for tirzepatide, a 3-month plan at $166 per month, a 6-month subscription at $140 per month, and a 12-month option described as 48 weekly injections in a single payment that renews at $1,500 every 47 weeks. Its 12-month semaglutide plan is described in the company’s own community channel as $1,068 total, or $89 per month, with all doses at the same price.
That structure solves the single most expensive problem in this market. Most competitors raise your price as you titrate; LumiMeds charges by commitment length instead, so a patient who reaches a maintenance dose does not watch their bill triple. On price mechanics alone, this is one of the better-designed offers we have reviewed.
There is, however, a fact that sits above the pricing and that no prospective patient should learn after enrolling. On September 9, 2025 the US Food and Drug Administration issued LumiMeds a warning letter (MARCS-CMS 716510) stating that, for the reasons set out in the letter, the company’s compounded semaglutide and tirzepatide products are misbranded drugs under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. The letter was part of a broader FDA enforcement sweep against telehealth companies marketing compounded GLP-1s. That is why this review is scored where it is, despite genuinely competitive pricing.
What Makes LumiMeds Different
Price Is Set by Commitment Length, Not Dose
LumiMeds structures plans around how long you commit rather than how many milligrams you take. Its own community materials state that all doses get the same price. Because GLP-1 protocols are designed to escalate, dose-independent pricing is worth substantially more over a year than a low entry rate.
No Membership Fee Layered on Top
The site states no membership is required. Two-part billing — a care fee plus a separate medication charge — is the norm in this market and makes cross-provider comparison difficult. A single figure is easier to evaluate.
Both Molecules, Published Rates
Compounded semaglutide and compounded tirzepatide are both offered with rates published on the site rather than quoted after an intake. Many competitors require you to complete a medical questionnaire before revealing a price.
An FDA Warning Letter on the Public Record
On September 9, 2025 the FDA issued LumiMeds a warning letter stating its compounded semaglutide and tirzepatide products are misbranded drugs under sections 502(a) and 502(bb) of the FD&C Act. Warning letters are published by the FDA and are searchable by anyone. This is the defining fact about the company at the time of writing.
✓ Pros
- •Among the lowest published prices anywhere — semaglutide from $89/month, tirzepatide from $125/month
- •Dose-independent pricing — the company states all doses get the same price
- •No membership fee — the site states no membership is required
- •Both molecules offered — compounded semaglutide and compounded tirzepatide
- •Rates published before intake — you can compare without submitting a health questionnaire
- •Plan lengths are clearly laid out — 3-month, 6-month and 12-month options with stated renewal terms
- •Responsive to public feedback — Trustpilot indicates the company replies to 95% of negative reviews
✗ Cons
- •FDA warning letter issued September 9, 2025 — products described by the agency as misbranded drugs
- •Long commitments carry the best pricing — the headline rates require 6- or 12-month prepayment
- •Compounded products are not FDA-approved — no agency review of safety, efficacy or manufacturing
- •Compounding pharmacy not named prominently — ask which facility dispenses and under what licensure
- •Mixed patient reports — public forum accounts include strongly negative experiences alongside positive ones
- •Prepayment raises the stakes on refunds — get cancellation and refund terms in writing first
- •Regulatory position of compounded GLP-1s has narrowed — since both molecules left the FDA shortage list
Our #1 Recommended Provider
LumiMeds is priced aggressively, but the September 2025 FDA warning letter is a fact we cannot look past. If you want low, published, dose-independent pricing without that overhang, Coreage RX remains our top recommendation.
Medications Offered
Brand-Name or Compounded?
Compounded only. LumiMeds offers compounded semaglutide and compounded tirzepatide. Compounded preparations are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or manufacturing quality. This distinction is especially important here: the FDA’s September 2025 warning letter to LumiMeds concerned exactly these products.
Compounded Semaglutide (GLP-1)
From $89/monthWeekly injection. LumiMeds describes a 12-month plan totalling $1,068, or $89 per month, with all doses priced the same. Shorter commitments cost more per month.
Compounded Tirzepatide (GLP-1/GIP)
From $125/monthWeekly injection of the dual agonist. Published plan tiers include $249/month monthly, $166/month on a 3-month plan and $140/month on a 6-month subscription, with a 12-month option covering 48 weekly injections in one payment that renews at $1,500 every 47 weeks.
NAD+ and Wellness Add-Ons
Priced separatelyLumiMeds lists additional wellness products alongside its GLP-1 plans. These are marketed around energy, focus and metabolism; the weight-loss benefit of such additions is not established by strong evidence. Treat them as optional and price them separately.
Before enrolling, ask LumiMeds three questions in writing: which pharmacy compounds your prescription and under what licensure, what the company’s response to the September 2025 FDA warning letter is, and exactly what happens to your prepayment if you stop treatment mid-plan.
Pricing, Membership & Medication Fees
| Cost Item | What You Pay |
|---|---|
| Compounded semaglutide | Plans from $89/month; 12-month plan described as $1,068 total |
| Compounded tirzepatide | Plans from $125/month; $249 monthly, $166/month on 3-month, $140/month on 6-month |
| 12-month tirzepatide option | 48 weekly injections in one payment, renewing at $1,500 every 47 weeks |
| Membership fee | None — the site states no membership is required |
| Dose escalation surcharge | None stated — the company describes the same price at every dose |
| Shipping | Confirm whether shipping is included at your plan tier |
| Insurance | Compounded medications are generally not covered by insurance; this is a cash-pay model |
| HSA / FSA | Prescription and eligible medical costs are often HSA/FSA eligible — confirm with your plan administrator |
The pricing is genuinely competitive and the structure is genuinely good. The question you have to answer is not whether $89 is a good price — it is — but whether you are comfortable buying a compounded product from a company the FDA has publicly told, in writing, that those products are misbranded.
How LumiMeds Works
Read the FDA Warning Letter First
The letter is published on the FDA website under LumiMeds, MARCS-CMS 716510, dated September 9, 2025. It is short and in plain language. Read it before you read the pricing page, not after.
Choose a Plan Length
LumiMeds prices by commitment rather than dose. The 12-month options carry the lowest monthly figures but require the largest prepayment. Match the commitment to how confident you are that you will stay on treatment.
Complete the Online Intake
You provide medical history, current medications, weight history and goals. A licensed provider reviews your submission. Be complete about thyroid history, pancreatitis, gallbladder disease and any family history of medullary thyroid carcinoma or MEN2.
Ask Which Pharmacy Dispenses
LumiMeds does not name its compounding pharmacy prominently. Ask directly which facility prepares your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility — the FDA oversight differs meaningfully between the two.
Medication Ships to You
Injectable GLP-1s are temperature-sensitive. Confirm what shipping is included at your plan tier, inspect the cold pack on arrival, and refrigerate promptly. If a shipment arrives warm, contact the provider before using it.
Titrate With Clinical Oversight
Doses escalate gradually to manage gastrointestinal side effects. Confirm before you start how you reach a clinician between shipments and how quickly they respond, since a long commitment is worth much less without responsive care during titration.
Program Details at a Glance
| Detail | LumiMeds |
|---|---|
| Consultation process | Online intake reviewed by a licensed provider. LumiMeds states a licensed provider reviews every plan. |
| Eligibility | Adults meeting clinical criteria for GLP-1 therapy as assessed by the reviewing provider. Confirm the specific BMI and comorbidity thresholds applied. |
| Provider involvement | Provider review at intake and treatment described as adjusted over time. Confirm how you reach a clinician between refills and the expected response time. |
| Lab requirements | Not prominently published. Ask whether baseline labs are required or recommended for your situation. |
| Pharmacy fulfillment | Compounded preparations are dispensed through a compounding pharmacy. LumiMeds does not name the facility prominently — ask directly, and ask whether it is 503A or 503B. |
| Shipping frequency | Aligned to plan length. Multi-month plans may ship in consolidated batches; confirm the schedule and refrigeration requirements before ordering. |
| Support services | Ongoing support from licensed providers is advertised. Confirm the channel — message, phone or video — and the hours. |
| Membership fee | None. The site states no membership is required. |
| Medication fee | The plan price is the medication price. Semaglutide from $89/month, tirzepatide from $125/month depending on commitment length. |
| Cancellation policy | Not prominently published. Because the best rates require prepayment, get cancellation terms in writing before you pay. |
| Refund policy | Not prominently published. Ask specifically what is refunded if you stop mid-plan after medication has shipped. |
| Insurance | Cash-pay model. Compounded medications are generally not covered by commercial insurance. |
| HSA / FSA | Prescription and eligible medical expenses are commonly HSA/FSA eligible. Confirm with your plan administrator and request itemised receipts. |
| States served | Availability depends on clinician licensure in your state. Confirm before enrolling. |
| Regulatory status | FDA warning letter issued September 9, 2025 (MARCS-CMS 716510) stating the company’s compounded semaglutide and tirzepatide products are misbranded drugs under sections 502(a) and 502(bb) of the FD&C Act. |
Who LumiMeds Is Best For
✓ Best For:
- • Price-driven patients who have read the FDA warning letter and decided they are comfortable with it
- • Patients who want dose-independent pricing rather than a low entry rate that escalates
- • People confident enough in staying on treatment to prepay a longer commitment
- • Patients who want both molecules available from one provider at published rates
- • Anyone who wants to avoid two-part billing with a separate membership fee
✗ Not Best For:
- • Anyone who wants a provider with no FDA enforcement action on the public record
- • Patients who want FDA-approved brand-name medication rather than compounded product
- • People who want the compounding pharmacy named and verifiable before they order
- • Patients unwilling or unable to prepay for a multi-month plan
- • Anyone who wants published cancellation and refund terms before enrolling
- • Patients who want bundled dietitian, coaching or labs as part of the programme
Limitations to Know Before You Sign Up
- ⚠The FDA issued LumiMeds a warning letter on September 9, 2025 stating that its compounded semaglutide and tirzepatide products are misbranded drugs. This is a published, verifiable enforcement action and it is the single most important thing to weigh against the pricing.
- ⚠Compounded semaglutide and tirzepatide are not FDA-approved. The agency has not reviewed them for safety, efficacy or manufacturing quality, and the regulatory position of compounded GLP-1s narrowed after both molecules left the FDA shortage list.
- ⚠The lowest advertised prices require 6- or 12-month commitments. Prepaying a year of treatment to a provider under FDA scrutiny concentrates your financial risk.
- ⚠The compounding pharmacy is not named prominently. Ask which facility dispenses your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
- ⚠Cancellation and refund terms are not prominently published, which matters more here than at a month-to-month provider because of the prepayment structure.
- ⚠Public patient feedback is genuinely mixed — a substantial Trustpilot presence sits alongside strongly negative accounts in patient forums. Read both before deciding.
Alternatives to LumiMeds
Coreage RX
Our top-rated provider at a published flat $99/month covering both molecules, with 503B sourcing disclosed and no FDA enforcement action on record.
Gimme Care
All-inclusive pricing from $130/month on a 3-month plan, same price at every dose, with a published refund policy.
Trimi
Publishes its compounding pharmacy names and state licence details rather than requiring you to ask.
LillyDirect
Manufacturer channel for FDA-approved Zepbound with published self-pay pricing, if compounded product is not for you.
Frequently Asked Questions
How much does LumiMeds cost?
LumiMeds advertises compounded semaglutide plans from $89 per month and compounded tirzepatide from $125 per month. Published tirzepatide tiers include $249 monthly, $166 per month on a 3-month plan and $140 per month on a 6-month subscription, with a 12-month option covering 48 weekly injections in one payment that renews at $1,500 every 47 weeks. The company’s 12-month semaglutide plan is described as $1,068 total. The site states no membership is required.
Did LumiMeds receive an FDA warning letter?
Yes. On September 9, 2025 the FDA issued LumiMeds a warning letter, published as MARCS-CMS 716510, stating that for the reasons discussed in the letter the company’s compounded semaglutide and tirzepatide products are misbranded drugs under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. The letter is public and searchable on the FDA website. It formed part of a wider FDA action against telehealth companies marketing compounded GLP-1s.
Does the price go up as my dose increases?
LumiMeds prices by commitment length rather than by dose, and its own community materials state that all doses get the same price. That is meaningfully better than the dose-tiered model most competitors use. Confirm it in writing for your specific plan before you prepay.
Is there a membership fee?
No. LumiMeds states on its site that no membership is required, so the plan price is the total price rather than a care fee plus a separate medication charge.
Which pharmacy compounds LumiMeds medication?
LumiMeds does not name its compounding pharmacy prominently in its public materials. Ask directly which facility prepares your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility, since FDA oversight differs substantially between the two categories.
Are LumiMeds medications FDA-approved?
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA has not reviewed them for safety, efficacy or manufacturing quality. The active ingredients are approved in commercial formulations; the compounded preparations are not.
Can I cancel a multi-month plan?
Cancellation and refund terms are not prominently published. Because the lowest prices require prepaying for 6 or 12 months, get the cancellation and refund terms in writing before you pay — specifically what happens if you stop after medication has already shipped.
Is LumiMeds safe to use?
That is a decision for you and a clinician who knows your history, but you should make it with the full picture. The pricing structure is sound and the company has a large public review presence. It also has a published FDA warning letter stating its GLP-1 products are misbranded drugs. Read the letter, discuss compounded GLP-1s with your own clinician, and compare against providers with no comparable enforcement action.
The Bottom Line
LumiMeds earns 2.5 out of 5 stars — genuinely excellent price architecture attached to a company carrying an FDA warning letter about the exact products it sells.
Take the pricing on its own and it is one of the better offers in this market. Semaglutide from $89 per month and tirzepatide from $125, with no membership fee and the same price at every dose, solves the dose-escalation trap that costs patients thousands of dollars a year at dose-tiered competitors. The plan tiers are published clearly, and you can compare them before submitting a health questionnaire.
But the September 9, 2025 FDA warning letter is not a technicality and it is not old news that has been resolved in public. The agency stated in writing that the company’s compounded semaglutide and tirzepatide products are misbranded drugs under sections 502(a) and 502(bb). That letter formed part of a broader FDA enforcement sweep across telehealth companies marketing compounded GLP-1s, and it is published where any patient can read it.
Our recommendation: read the FDA letter before you read anything else about this company, then decide. If you conclude the price justifies the risk, at minimum insist on the pharmacy name and licensure, and avoid a 12-month prepayment until you have cancellation terms in writing. If you want comparable dose-independent pricing without the regulatory overhang, Coreage RX at a flat $99 and Gimme Care from $130 on a 3-month plan are both worth pricing first.
Disclosure:
This review is based on publicly available information from LumiMeds’ own website and community channels, and on the FDA warning letter to LumiMeds published as MARCS-CMS 716510 and dated September 9, 2025, all current as of August 27, 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with LumiMeds. Pricing, plan structures and product availability change frequently in this market — confirm all figures directly before enrolling. Compounded medications are not FDA-approved and their regulatory position narrowed after semaglutide and tirzepatide left the FDA shortage list. We do not sell, dispense, or ship medication.
⚕ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. Prescription weight-management medications carry serious risks and contraindications; GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider